Jason S O'Connor

US Patent:

20090143732, Jun 4, 2009

Filed:

Nov 29, 2007

Appl. No.:

11/947117

Inventors:

Jason B. O'Connor - South Boston MA, US
Luis Malave - Reading MA, US

Assignee:

INSULET CORPORATION - Bedford MA

International Classification:

A61M 5/142

US Classification:

604151

Abstract:

A prefilled syringe may be interfaced with and used to fill an infusion pump with therapeutic liquid. The dispensing end of the prefilled syringe may be coupled (either directly or indirectly using a syringe cap) to a syringe coupling region of the infusion pump, for example, using a threaded engagement or snap fit engagement. As the dispensing end of the prefilled syringe is coupled to the syringe coupling region of the pump housing, a needle passes through the pump housing and/or a needle passage region of the dispensing end such that the prefilled syringe is fluidly coupled to a reservoir in the pump. In various embodiments, the needle may be located in the syringe coupling region or in a syringe cap coupled to the dispensing end of the prefilled syringe.

US Patent:

20220293234, Sep 15, 2022

Filed:

Mar 10, 2022

Appl. No.:

17/691829

Inventors:

- Acton MA, US
Eric BENJAMIN - Cambridge MA, US
Jason O'CONNOR - Acton MA, US
Yibin ZHENG - Hartland WI, US

International Classification:

G16H 20/13
A61M 5/172

Abstract:

The exemplary embodiments may modify a glucose cost component of the cost function of the control loop of an insulin delivery device to compensate for persistent positive low level glucose excursions relative to a target glucose level. The exemplary embodiments may enable use of different glucose cost component functions for different glucose levels of the user. These glucose cost component functions may be employed in piecewise fashion with a different piece being applied for each respective range of glucose level values for the user. The final glucose cost function for calculating the glucose cost component may be a weighted combination of a piecewise glucose cost function and a weighted standard cost function (such as a quadratic function). The weights may reflect the magnitude and/or persistence of glucose excursions relative to a target glucose level.

US Patent:

20200069876, Mar 5, 2020

Filed:

Sep 12, 2019

Appl. No.:

16/568965

Inventors:

- Acton MA, US
Steven DiIanni - Groveland MA, US
Robert W. Campbell - Cumberland Foreside ME, US
Ian T. McLaughlin - Groton MA, US
Jason B. O'Connor - Acton MA, US

International Classification:

A61M 5/172
A61B 5/145
G16H 20/17
A61B 5/00
A61B 5/1486
A61M 5/142

Abstract:

A physiological parameter associated with tissue of a host may be monitored in the tissue to confirm subcutaneous delivery of medication to the host. More particularly, such may involve delivering medication subcutaneously to the host with a medical device which includes a sensor used to measure the physiological parameter, particularly within a predetermined time period after delivery of the medication. Such may also or otherwise involve forming a depot in the tissue with the medication, and using the sensor to measure the physiological parameter while the sensor is at least partially within the depot.

US Patent:

20190336682, Nov 7, 2019

Filed:

May 2, 2018

Appl. No.:

15/969295

Inventors:

- Acton MA, US
David NAZZARO - Groveland MA, US
Jason O'CONNOR - Acton MA, US
Aiman Albert ABDEL-MALEK - La Jolla CA, US

International Classification:

A61M 5/172
A61M 5/142
G16H 20/10
G06K 7/00
G06K 7/14
G06K 7/10

Abstract:

A drug delivery system is provided. The drug delivery system can include a drug delivery device configured to store and deliver a drug to a user and a drug delivery management device for managing operation of the drug delivery device. The drug delivery management device can determine information relating to the drug that is to be provided to the user. The information relating to the drug can be provided by an indicator coupled to a container configured to store the drug. The drug delivery management device can determine a software program for controlling operation of the drug delivery management device based on the determined information relating to the drug. Other embodiments are disclosed and described.